DaVita Inc. (NYSE:DVA) Shares Sold by Securian Asset Management Inc.

Securian Asset Management Inc. lessened its stake in DaVita Inc. (NYSE:DVA) by 11.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,252 shares of the company’s stock after selling 300 shares during the quarter. Securian Asset Management Inc.’s holdings in DaVita were worth $337,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the stock. JPMorgan Chase & Co. lifted its holdings in shares of DaVita by 17.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 609,076 shares of the company’s stock valued at $99,846,000 after buying an additional 92,014 shares during the period. Amundi raised its holdings in DaVita by 116.4% in the 4th quarter. Amundi now owns 446,386 shares of the company’s stock worth $68,726,000 after purchasing an additional 240,126 shares during the period. KBC Group NV raised its holdings in DaVita by 0.8% in the 4th quarter. KBC Group NV now owns 316,155 shares of the company’s stock worth $47,281,000 after purchasing an additional 2,636 shares during the period. BNP Paribas Financial Markets raised its holdings in DaVita by 23.9% in the 3rd quarter. BNP Paribas Financial Markets now owns 292,039 shares of the company’s stock worth $47,874,000 after purchasing an additional 56,389 shares during the period. Finally, Nordea Investment Management AB raised its holdings in DaVita by 4.9% in the 4th quarter. Nordea Investment Management AB now owns 264,535 shares of the company’s stock worth $39,712,000 after purchasing an additional 12,339 shares during the period. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Price Performance

NYSE:DVA opened at $149.27 on Wednesday. DaVita Inc. has a 12 month low of $125.64 and a 12 month high of $179.60. The stock has a 50 day moving average of $158.80 and a two-hundred day moving average of $157.61. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. The firm has a market cap of $11.94 billion, a P/E ratio of 13.90, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, analysts expect that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

DVA has been the subject of a number of analyst reports. Barclays upped their price target on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. Cowen reaffirmed a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price target on DaVita in a report on Friday, February 21st. One analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, DaVita has a consensus rating of “Hold” and a consensus price target of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.